127 related articles for article (PubMed ID: 16730122)
1. Influence of lysosomal acid lipase polymorphisms on chromosome 10 on the risk of Alzheimer's disease and cholesterol metabolism.
von Trotha KT; Heun R; Schmitz S; Lütjohann D; Maier W; Kölsch H
Neurosci Lett; 2006 Jul; 402(3):262-6. PubMed ID: 16730122
[TBL] [Abstract][Full Text] [Related]
2. PPARD haplotype influences cholesterol metabolism but is no risk factor of Alzheimer's disease.
Holzapfel J; Heun R; Lütjohann D; Jessen F; Maier W; Kölsch H
Neurosci Lett; 2006 Nov; 408(1):57-61. PubMed ID: 16979821
[TBL] [Abstract][Full Text] [Related]
3. Association analysis of genes involved in cholesterol metabolism located within the linkage region on chromosome 10 and Alzheimer's disease.
Riemenschneider M; Mahmoodzadeh S; Eisele T; Klopp N; Schwarz S; Wagenpfeil S; Diehl J; Mueller U; Foerstl H; Illig T; Kurz A
Neurobiol Aging; 2004; 25(10):1305-8. PubMed ID: 15465627
[TBL] [Abstract][Full Text] [Related]
4. CETP polymorphisms influence cholesterol metabolism but not Alzheimer's disease risk.
Qureischie H; Heun R; Lütjohann D; Popp J; Jessen F; Ledschbor-Frahnert C; Thiele H; Maier W; Hentschel F; Kelemen P; Kölsch H
Brain Res; 2008 Sep; 1232():1-6. PubMed ID: 18680734
[TBL] [Abstract][Full Text] [Related]
5. APOA1 polymorphism influences risk for early-onset nonfamiliar AD.
Vollbach H; Heun R; Morris CM; Edwardson JA; McKeith IG; Jessen F; Schulz A; Maier W; Kölsch H
Ann Neurol; 2005 Sep; 58(3):436-41. PubMed ID: 16130094
[TBL] [Abstract][Full Text] [Related]
6. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
Yao L; Li K; Zhang L; Yao S; Piao Z; Song L
Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630
[TBL] [Abstract][Full Text] [Related]
7. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
Hong GS; Heun R; Jessen F; Popp J; Hentschel F; Kelemen P; Schulz A; Maier W; Kölsch H
Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251
[TBL] [Abstract][Full Text] [Related]
8. Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease.
Ozturk A; Desai PP; Minster RL; Dekosky ST; Kamboh MI
Neurobiol Aging; 2005; 26(8):1161-5. PubMed ID: 15917099
[TBL] [Abstract][Full Text] [Related]
9. Association of LIPA gene polymorphisms with obesity-related metabolic complications among severely obese patients.
Guénard F; Houde A; Bouchard L; Tchernof A; Deshaies Y; Biron S; Lescelleur O; Biertho L; Marceau S; Pérusse L; Vohl MC
Obesity (Silver Spring); 2012 Oct; 20(10):2075-82. PubMed ID: 22395809
[TBL] [Abstract][Full Text] [Related]
10. Association of an interleukin-1beta gene polymorphism at position -511 with Alzheimer's disease.
Ehl C; Kölsch H; Ptok U; Jessen F; Schmitz S; Frahnert C; Schlösser R; Rao ML; Maier W; Heun R
Int J Mol Med; 2003 Feb; 11(2):235-8. PubMed ID: 12525884
[TBL] [Abstract][Full Text] [Related]
11. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
[TBL] [Abstract][Full Text] [Related]
12. Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Bifaro L; Menga R; Santamato A; Seripa D; Pilotto A; Capurso A; Panza F
Neurosci Lett; 2008 Feb; 432(3):237-42. PubMed ID: 18248894
[TBL] [Abstract][Full Text] [Related]
13. The hydroxy-methyl-glutaryl CoA reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deterioration.
Porcellini E; Calabrese E; Guerini F; Govoni M; Chiappelli M; Tumini E; Morgan K; Chappell S; Kalsheker N; Franceschi M; Licastro F
Neurosci Lett; 2007 Apr; 416(1):66-70. PubMed ID: 17284348
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer's disease susceptibility.
Yu JT; Tan L; Ou JR; Zhu JX; Liu K; Song JH; Sun YP
Brain Res; 2008 May; 1210():216-22. PubMed ID: 18423577
[TBL] [Abstract][Full Text] [Related]
16. Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease.
Depboylu C; Lohmüller F; Du Y; Riemenschneider M; Kurz A; Gasser T; Müller U; Dodel RC
Neurosci Lett; 2006 Jun; 400(3):187-90. PubMed ID: 16650578
[TBL] [Abstract][Full Text] [Related]
17. The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease.
Vural P; Değirmencioğlu S; Parildar-Karpuzoğlu H; Doğru-Abbasoğlu S; Hanagasi HA; Karadağ B; Gürvit H; Emre M; Uysal M
Acta Neurol Scand; 2009 Dec; 120(6):396-401. PubMed ID: 19744138
[TBL] [Abstract][Full Text] [Related]
18. The H+ allele of the lipoprotein lipase (LPL) HindIII intronic polymorphism and the risk for sporadic late-onset Alzheimer's disease.
Scacchi R; Gambina G; Broggio E; Moretto G; Ruggeri M; Corbo RM
Neurosci Lett; 2004 Sep; 367(2):177-80. PubMed ID: 15331147
[TBL] [Abstract][Full Text] [Related]
19. Candidate gene analysis of IP-10 gene in patients with Alzheimer's disease.
Venturelli E; Galimberti D; Fenoglio C; Lovati C; Finazzi D; Guidi I; Corrà B; Scalabrini D; Clerici F; Mariani C; Forloni G; Bresolin N; Scarpini E
Neurosci Lett; 2006 Aug; 404(1-2):217-21. PubMed ID: 16787707
[TBL] [Abstract][Full Text] [Related]
20. Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease.
Nishimura M; Sakamoto T; Kaji R; Kawakami H
Neurosci Lett; 2004 Sep; 368(2):140-3. PubMed ID: 15351436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
